- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04501172
Impact of Spectacles on Compliance to Mask-wearing Directives
Impact of Spectacles on Compliance to Mask-wearing Directives in Greece
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Evros
-
Alexandroupolis, Evros, Greece, 68100
- University Hospital of Alexandroupolis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age >18 years old
- Adequate literacy of Greek language
- Permanent residence in Greece
Exclusion Criteria:
- Poor knowledge of Greek language
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study group
People who use social networks, with permanent residence in Greece, aged above 18 years old and adequate literacy of Greek language
|
Participants are contacted through social networks (Facebook) which provide a link to website that contains the questionnaire. Then, they complete the questionnaire which consists of the following 2 parts:
The impact of spectacles on the compliance of Greek people to mask-wearing directives will be assessed via this questionnaire. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demographic characteristics
Time Frame: last 3 months
|
|
last 3 months
|
|
Compliance to mask-wearing directives
Time Frame: last 3 months
|
Compliance to mask-wearing directives
|
last 3 months
|
|
Questionnaire subscale: Near vision
Time Frame: last 3 months
|
Difficulty in near vision activities (reading a printed document in the workplace or in daily life, reading a document on computer in the workplace or in daily life, reading a message on mobile phone) when using a face mask
|
last 3 months
|
|
Questionnaire subscale: Distance vision
Time Frame: last 3 months
|
Difficulty in distance vision activities (recognizing people on the opposite sidewalk, reading road and shop signs, crossing roads) when using a face mask
|
last 3 months
|
|
Questionnaire subscale: Ocular discomfort
Time Frame: last 3 months
|
Ocular discomfort (tearing sensation, stinging sensation, general discomfort) when using a face mask 5-point Likert scale (1 = I absolutely agree / 5 = I absolutely disagree) |
last 3 months
|
|
Questionnaire subscale: Driving
Time Frame: last 3 months
|
Difficulty in driving (during day or night, in known or unknown places) when using a face mask
|
last 3 months
|
|
Questionnaire subscale: Limitation
Time Frame: last 3 months
|
Limitation during physical activity, entertainment, social relationships, professional and learning development when using a face mask 5-point Likert scale (1 = I absolutely agree / 5 = I absolutely disagree) |
last 3 months
|
|
Questionnaire subscale: Collaboration
Time Frame: last 3 months
|
Difficulty in collaboration with colleagues in the workplace when using a face mask
|
last 3 months
|
|
Questionnaire subscale: Need for help
Time Frame: last 3 months
|
Need for help during shopping (supermarket, grocery store, bakery) or in public services (bank etc) when using a face mask 5-point Likert scale (1 = I absolutely agree / 5 = I absolutely disagree) |
last 3 months
|
|
Questionnaire subscale: Emotional impact
Time Frame: last 3 months
|
Emotional charge when using a face mask 5-point Likert scale (1 = I absolutely agree / 5 = I absolutely disagree) |
last 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of the relationship between the compliance to mask-wearing directives and the use of spectacles
Time Frame: immediately after the completion of data collection
|
Chi-squared test will be performed to assess if the compliance to mask-wearing directives is related to the use of spectacles
|
immediately after the completion of data collection
|
|
Assessment of the relationship between the compliance to mask-wearing directives and the other demographic characteristics
Time Frame: immediately after the completion of data collection
|
Chi-squared test will be performed to assess if the compliance to mask-wearing directives is related to the other demographic characteristics
|
immediately after the completion of data collection
|
|
Assessment of the relationship between the compliance to mask-wearing directives and the questionnaire items
Time Frame: immediately after the completion of data collection
|
Chi-squared test will be performed to assess if the compliance to mask-wearing directives is related to the 20 questionnaire items and the corresponding subscales (outcome measures 3-10)
|
immediately after the completion of data collection
|
|
Assessment of the relationship between demographic characteristics and the 20 questionnaire items
Time Frame: immediately after the completion of data collection
|
Chi-squared test will be performed to assess if demographic characteristics are related to the 20 items of the questionnaire and to the corresponding subscales (outcome measures 3-10)
|
immediately after the completion of data collection
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Labiris Georgios, MD, PhD, Department of Ophthalmolgy, University Hospital of Alexandroupolis, Greece
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ES8/Th5/25-06-2020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
-
Erasmus Medical CenterUniversity Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruiting
Clinical Trials on Questionnaire completion
-
Institut du Cancer de Montpellier - Val d'AurelleNot yet recruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingDiabetes type1 | Diabetes, Gestational | Diabetes Type 2Réunion
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Institut Claudius RegaudLigue contre le cancer, FranceCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedHereditary Spastic ParaplegiaFrance
-
University Hospital, Clermont-FerrandMerck Santé SASUnknownCognitive Dysfunction | Sclerosis, MultipleFrance
-
Groupe d'Etude Therapeutique des Affections Inflammatoires...Not yet recruiting
-
University Hospital, AngersUnknownIdiopathic Thrombocytopenic PurpuraFrance
-
University Hospital, AngersCompletedFood Allergy in Children | 6 Years Old MaximumFrance